______
Call all oncology professionals - Be sure to reserve some time on your calendar for MSCO!
The MSCO Webinar Series: OncoInsights is an exciting evening webinar on the first Wednesday of each month. We'll include a mixture of industry partners and CME webinars featuring a range of topics. Don't miss out on the opportunity to stay up-to-date on the latest advancements in oncology. Join us for an engaging and informative session with leading experts.
Register once, and you're on the list for the entire 2025 series!
We look forward to seeing you!
______
December 10, 2025: CELMoD Agents in Multiple Myeloma
Presented in partnership with Bristol Myers Squibb
Speaker: Brian Engelhardt, MD, MSCI - Director and Multiple Myeloma Medical Engagement Lead, Bristol Myers Squibb
Learning Objectives:
- Learn about a new class of drugs currently in development for Multiple Myeloma
- Learn about clinical data on CELMoD Agents in Multiple Myeloma
- When and where these drugs will be used once approved
June 11, 2025: Small Cell Lung Cancer: A Review of Epidemiology, Treatment Landscape, and Long-term management
Presented in partnership with Jazz Pharmaceuticals
Speaker: Joshua Sabari, MD; Thoracic Medical Oncologist at NYU Langone Health
Learning Objectives:
- Understand the aggressive nature of SCLC and disease characteristics
- Review SCLC diagnosis, staging, and treatment, with an emphasis on the role of imaging for detecting progression and informing treatment decisions
- Gain insights on treatment considerations and management strategies for SCLC patients
View Recording >
______
July 09, 2025: Transplant Oncology – An Evolution of Multidisciplinary Liver Cancer Care
*Please Note- The MSCO Webinar Session scheduled for July 9th @5:00PM is Canceled!
Speaker: M. Valerie Lin, MD; Director of Liver Tumor Clinic, Division of Transplantation & Hepatobiliary Diseases, Lahey Hospital and Medical Center
Objectives:
- Review the concept of transplant oncology
- Discuss the management of hepatocellular carcinoma
- Discuss the use of immune checkpoint inhibitors in pre- and post-liver transplant setting
- Review OPTN/UNOS transplant guidelines on perihilar and intrahepatic cholangiocarcinoma (hCCA and iCCA), and colorectal liver metastasis (CRLM)
